Strategic use of new generation antidepressants for depression: SUN(^_^) D protocol update and statistical analysis plan

Naohiro Yonemoto, Shiro Tanaka, Toshi A. Furukawa, Tadashi Kato, Akio Mantani, Yusuke Ogawa, Aran Tajika, Nozomi Takeshima, Yu Hayasaka, Kiyomi Shinohara, Kazuhira Miki, Masatoshi Inagaki, Shinji Shimodera, Tatsuo Akechi, Mitsuhiko Yamada, Norio Watanabe, Gordon H. Guyatt

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: SUN(^_^)D, the Strategic Use of New generation antidepressants for Depression, is an assessor-blinded, parallel-group, multicenter pragmatic mega-trial to examine the optimum treatment strategy for the first- and second-line treatments for unipolar major depressive episodes. The trial has three steps and two randomizations. Step I randomization compares the minimum and the maximum dosing strategy for the first-line antidepressant. Step II randomization compares the continuation, augmentation or switching strategy for the second-line antidepressant treatment. Step III is a naturalistic continuation phase. The original protocol was published in 2011, and we hereby report its updated protocol including the statistical analysis plan. Results: We implemented two important changes to the original protocol. One is about the required sample size, reflecting the smaller number of dropouts than had been expected. Another is in the organization of the primary and secondary outcomes in order to make the report of the main trial results as pertinent and interpretable as possible for clinical practices. Due to the complexity of the trial, we plan to report the main results in two separate reports, and this updated protocol and the statistical analysis plan have laid out respective primary and secondary outcomes and their analyses. We will convene the blind interpretation committee before the randomization code is broken. Conclusion: This paper presents the updated protocol and the detailed statistical analysis plan for the SUN(^_^)D trial in order to avoid reporting bias and data-driven results. Trial registration: ClinicalTrials.gov: NCT01109693(registered on 21 April 2010).

Original languageEnglish
JournalTrials
Volume16
Issue number1
DOIs
Publication statusPublished - Oct 14 2015

Fingerprint

Random Allocation
Antidepressive Agents
Pragmatic Clinical Trials
Sample Size
Research Design

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology (medical)

Cite this

Yonemoto, N., Tanaka, S., Furukawa, T. A., Kato, T., Mantani, A., Ogawa, Y., ... Guyatt, G. H. (2015). Strategic use of new generation antidepressants for depression: SUN(^_^) D protocol update and statistical analysis plan. Trials, 16(1). https://doi.org/10.1186/s13063-015-0985-6

Strategic use of new generation antidepressants for depression : SUN(^_^) D protocol update and statistical analysis plan. / Yonemoto, Naohiro; Tanaka, Shiro; Furukawa, Toshi A.; Kato, Tadashi; Mantani, Akio; Ogawa, Yusuke; Tajika, Aran; Takeshima, Nozomi; Hayasaka, Yu; Shinohara, Kiyomi; Miki, Kazuhira; Inagaki, Masatoshi; Shimodera, Shinji; Akechi, Tatsuo; Yamada, Mitsuhiko; Watanabe, Norio; Guyatt, Gordon H.

In: Trials, Vol. 16, No. 1, 14.10.2015.

Research output: Contribution to journalArticle

Yonemoto, N, Tanaka, S, Furukawa, TA, Kato, T, Mantani, A, Ogawa, Y, Tajika, A, Takeshima, N, Hayasaka, Y, Shinohara, K, Miki, K, Inagaki, M, Shimodera, S, Akechi, T, Yamada, M, Watanabe, N & Guyatt, GH 2015, 'Strategic use of new generation antidepressants for depression: SUN(^_^) D protocol update and statistical analysis plan', Trials, vol. 16, no. 1. https://doi.org/10.1186/s13063-015-0985-6
Yonemoto, Naohiro ; Tanaka, Shiro ; Furukawa, Toshi A. ; Kato, Tadashi ; Mantani, Akio ; Ogawa, Yusuke ; Tajika, Aran ; Takeshima, Nozomi ; Hayasaka, Yu ; Shinohara, Kiyomi ; Miki, Kazuhira ; Inagaki, Masatoshi ; Shimodera, Shinji ; Akechi, Tatsuo ; Yamada, Mitsuhiko ; Watanabe, Norio ; Guyatt, Gordon H. / Strategic use of new generation antidepressants for depression : SUN(^_^) D protocol update and statistical analysis plan. In: Trials. 2015 ; Vol. 16, No. 1.
@article{26b1aaba7ffa47388276d41db6567dfe,
title = "Strategic use of new generation antidepressants for depression: SUN(^_^) D protocol update and statistical analysis plan",
abstract = "Background: SUN(^_^)D, the Strategic Use of New generation antidepressants for Depression, is an assessor-blinded, parallel-group, multicenter pragmatic mega-trial to examine the optimum treatment strategy for the first- and second-line treatments for unipolar major depressive episodes. The trial has three steps and two randomizations. Step I randomization compares the minimum and the maximum dosing strategy for the first-line antidepressant. Step II randomization compares the continuation, augmentation or switching strategy for the second-line antidepressant treatment. Step III is a naturalistic continuation phase. The original protocol was published in 2011, and we hereby report its updated protocol including the statistical analysis plan. Results: We implemented two important changes to the original protocol. One is about the required sample size, reflecting the smaller number of dropouts than had been expected. Another is in the organization of the primary and secondary outcomes in order to make the report of the main trial results as pertinent and interpretable as possible for clinical practices. Due to the complexity of the trial, we plan to report the main results in two separate reports, and this updated protocol and the statistical analysis plan have laid out respective primary and secondary outcomes and their analyses. We will convene the blind interpretation committee before the randomization code is broken. Conclusion: This paper presents the updated protocol and the detailed statistical analysis plan for the SUN(^_^)D trial in order to avoid reporting bias and data-driven results. Trial registration: ClinicalTrials.gov: NCT01109693(registered on 21 April 2010).",
author = "Naohiro Yonemoto and Shiro Tanaka and Furukawa, {Toshi A.} and Tadashi Kato and Akio Mantani and Yusuke Ogawa and Aran Tajika and Nozomi Takeshima and Yu Hayasaka and Kiyomi Shinohara and Kazuhira Miki and Masatoshi Inagaki and Shinji Shimodera and Tatsuo Akechi and Mitsuhiko Yamada and Norio Watanabe and Guyatt, {Gordon H.}",
year = "2015",
month = "10",
day = "14",
doi = "10.1186/s13063-015-0985-6",
language = "English",
volume = "16",
journal = "Trials",
issn = "1745-6215",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Strategic use of new generation antidepressants for depression

T2 - SUN(^_^) D protocol update and statistical analysis plan

AU - Yonemoto, Naohiro

AU - Tanaka, Shiro

AU - Furukawa, Toshi A.

AU - Kato, Tadashi

AU - Mantani, Akio

AU - Ogawa, Yusuke

AU - Tajika, Aran

AU - Takeshima, Nozomi

AU - Hayasaka, Yu

AU - Shinohara, Kiyomi

AU - Miki, Kazuhira

AU - Inagaki, Masatoshi

AU - Shimodera, Shinji

AU - Akechi, Tatsuo

AU - Yamada, Mitsuhiko

AU - Watanabe, Norio

AU - Guyatt, Gordon H.

PY - 2015/10/14

Y1 - 2015/10/14

N2 - Background: SUN(^_^)D, the Strategic Use of New generation antidepressants for Depression, is an assessor-blinded, parallel-group, multicenter pragmatic mega-trial to examine the optimum treatment strategy for the first- and second-line treatments for unipolar major depressive episodes. The trial has three steps and two randomizations. Step I randomization compares the minimum and the maximum dosing strategy for the first-line antidepressant. Step II randomization compares the continuation, augmentation or switching strategy for the second-line antidepressant treatment. Step III is a naturalistic continuation phase. The original protocol was published in 2011, and we hereby report its updated protocol including the statistical analysis plan. Results: We implemented two important changes to the original protocol. One is about the required sample size, reflecting the smaller number of dropouts than had been expected. Another is in the organization of the primary and secondary outcomes in order to make the report of the main trial results as pertinent and interpretable as possible for clinical practices. Due to the complexity of the trial, we plan to report the main results in two separate reports, and this updated protocol and the statistical analysis plan have laid out respective primary and secondary outcomes and their analyses. We will convene the blind interpretation committee before the randomization code is broken. Conclusion: This paper presents the updated protocol and the detailed statistical analysis plan for the SUN(^_^)D trial in order to avoid reporting bias and data-driven results. Trial registration: ClinicalTrials.gov: NCT01109693(registered on 21 April 2010).

AB - Background: SUN(^_^)D, the Strategic Use of New generation antidepressants for Depression, is an assessor-blinded, parallel-group, multicenter pragmatic mega-trial to examine the optimum treatment strategy for the first- and second-line treatments for unipolar major depressive episodes. The trial has three steps and two randomizations. Step I randomization compares the minimum and the maximum dosing strategy for the first-line antidepressant. Step II randomization compares the continuation, augmentation or switching strategy for the second-line antidepressant treatment. Step III is a naturalistic continuation phase. The original protocol was published in 2011, and we hereby report its updated protocol including the statistical analysis plan. Results: We implemented two important changes to the original protocol. One is about the required sample size, reflecting the smaller number of dropouts than had been expected. Another is in the organization of the primary and secondary outcomes in order to make the report of the main trial results as pertinent and interpretable as possible for clinical practices. Due to the complexity of the trial, we plan to report the main results in two separate reports, and this updated protocol and the statistical analysis plan have laid out respective primary and secondary outcomes and their analyses. We will convene the blind interpretation committee before the randomization code is broken. Conclusion: This paper presents the updated protocol and the detailed statistical analysis plan for the SUN(^_^)D trial in order to avoid reporting bias and data-driven results. Trial registration: ClinicalTrials.gov: NCT01109693(registered on 21 April 2010).

UR - http://www.scopus.com/inward/record.url?scp=84944411466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944411466&partnerID=8YFLogxK

U2 - 10.1186/s13063-015-0985-6

DO - 10.1186/s13063-015-0985-6

M3 - Article

C2 - 26466684

AN - SCOPUS:84944411466

VL - 16

JO - Trials

JF - Trials

SN - 1745-6215

IS - 1

ER -